185 related articles for article (PubMed ID: 25462860)
1. Frequent involvement of chromatin remodeler alterations in gastric field cancerization.
Takeshima H; Niwa T; Takahashi T; Wakabayashi M; Yamashita S; Ando T; Inagawa Y; Taniguchi H; Katai H; Sugiyama T; Kiyono T; Ushijima T
Cancer Lett; 2015 Feb; 357(1):328-338. PubMed ID: 25462860
[TBL] [Abstract][Full Text] [Related]
2. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect.
Ando T; Yoshida T; Enomoto S; Asada K; Tatematsu M; Ichinose M; Sugiyama T; Ushijima T
Int J Cancer; 2009 May; 124(10):2367-74. PubMed ID: 19165869
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
7. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS
Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic field for cancerization.
Ushijima T
J Biochem Mol Biol; 2007 Mar; 40(2):142-50. PubMed ID: 17394762
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers.
Ushijima T; Hattori N
Clin Cancer Res; 2012 Feb; 18(4):923-9. PubMed ID: 22205689
[TBL] [Abstract][Full Text] [Related]
10. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues.
Yamashita S; Kishino T; Takahashi T; Shimazu T; Charvat H; Kakugawa Y; Nakajima T; Lee YC; Iida N; Maeda M; Hattori N; Takeshima H; Nagano R; Oda I; Tsugane S; Wu MS; Ushijima T
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1328-1333. PubMed ID: 29358395
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic field cancerization in gastrointestinal cancers.
Baba Y; Ishimoto T; Kurashige J; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Baba H
Cancer Lett; 2016 Jun; 375(2):360-366. PubMed ID: 26971491
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae.
Kosumi K; Baba Y; Ishimoto T; Harada K; Miyake K; Izumi D; Tokunaga R; Murata A; Eto K; Sugihara H; Shigaki H; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Takeya M; Baba H
Med Oncol; 2015 Apr; 32(4):117. PubMed ID: 25782871
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
19. Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis.
Muhammad JS; Nanjo S; Ando T; Yamashita S; Maekita T; Ushijima T; Tabuchi Y; Sugiyama T
Int J Cancer; 2017 May; 140(10):2272-2283. PubMed ID: 28214334
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Zhang Y; Zhang XR; Park JL; Kim JH; Zhang L; Ma JL; Liu WD; Deng DJ; You WC; Kim YS; Pan KF
Oncotarget; 2016 Jun; 7(24):37132-37144. PubMed ID: 27206798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
